Highbridge Capital Management’s AbbVie ABBV Stock Holding History

Highbridge Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-71,495	Closed	-$6.62M	–	467
2018 Q2	$6.62M	Sell	71,495 -48,711	-41%	-$4.76M	0.13%	209
2018 Q1	$11.4M	Buy	+120,206	New	+$13.2M	0.18%	127
2017 Q4	–	Sell	-40,858	Closed	-$3.85M	–	1586
2017 Q3	$3.63M	Buy	40,858 +31,230	+324%	+$2.38M	0.05%	350
2017 Q2	$698K	Sell	9,628 -66,326	-87%	-$4.46M	0.01%	657
2017 Q1	$4.95M	Buy	+75,954	New	+$4.78M	0.07%	300
2016 Q3	–	Sell	-24,577	Closed	-$1.59M	–	1269
2016 Q2	$1.52M	Buy	24,577 +20,218	+464%	+$1.23M	0.02%	505
2016 Q1	$249K	Sell	4,359 -937,038	-100%	-$52.2M	﹤0.01%	1250
2015 Q4	$55.8M	Sell	941,397 -347,413	-27%	-$20M	0.85%	8
2015 Q3	$70.1M	Buy	1,288,810 +552,478	+75%	+$36M	1.08%	3
2015 Q2	$49.5M	Sell	736,332 -480,618	-39%	-$31.4M	0.62%	25
2015 Q1	$71.2M	Buy	1,216,950 +1,086,226	+831%	+$65.6M	0.98%	4
2014 Q4	$8.55M	Sell	130,724 -553,476	-81%	-$34.9M	0.11%	235
2014 Q3	$39.5M	Buy	684,200 +665,600	+3,578%	+$37M	0.52%	46
2014 Q2	$1.05M	Buy	18,600 +12,018	+183%	+$630K	0.01%	555
2014 Q1	$338K	Buy	+6,582	New	+$333K	﹤0.01%	807
2013 Q4	–	Sell	-1,245,018	Closed	-$55.7M	–	1028
2013 Q3	$55.7M	Buy	1,245,018 +141,495	+13%	+$6.27M	0.59%	21
2013 Q2	$45.6M	Buy	+1,103,523	New	+$48.3M	0.45%	35

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Highbridge Capital Management's ABBV Position: Q3 2018 in Review

Highbridge Capital Management sold out of AbbVie (ABBV) in Q3 2018, closing a stake of 71,495 shares — an estimated $6.62M sold.

Highbridge Capital Management first reported a position in ABBV in Q2 2013 and held it in 17 quarters. The position peaked at $71.2M in Q1 2015. 1,957 funds tracked by Wall St. Rank hold ABBV as of Q3 2018.

Highbridge Capital Management reported no remaining AbbVie position as of Q3 2018 after selling out during the quarter.
Highbridge Capital Management sold 71,495 AbbVie shares in Q3 2018, an estimated $6.62M.
Highbridge Capital Management first reported a position in AbbVie in Q2 2013 and held it in 17 quarters.
Highbridge Capital Management's AbbVie position peaked at $71.2M in Q1 2015.
1,957 funds tracked by Wall St. Rank held AbbVie as of Q3 2018.

Based on Highbridge Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.